Blepharospasm drugs in development, 2023

GlobalData tracks 5 drugs in development for Blepharospasm by four companies/universities/institutes. The top development phase for Blepharospasm is phase ii, with two drugs in that stage.

New study maps the spread of brain changes in psychosis

Psychoses like schizophrenia cost billions of dollars annually and derail the lives of people struggling with the disease.

September 21, 2023

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 14, 2024

MHRA reveals new corporate plan to expedite drug regulatory journeys in UK

The MHRA has revealed its corporate plan for the upcoming three years. Credit: Shutterstock / lazyllama. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA)

July 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.